tramadol ER
Selected indexed studies
- Tramadol extended-release tablets. (Drugs, 2006) [PMID:17100415]
- Tramadol. (, 2006) [PMID:30000319]
- Tramadol--Biovail Corporation. (Drugs R D, 2004) [PMID:15139783]
_Worker-drafted node — pending editorial review._
Connections
tramadol ER is a side effect of
Sources
- Tramadol extended-release tablets. (2006) pubmed
- Oral hydromorphone extended-release. (2010) pubmed
- Tramadol Therapy and CYP2D6 Genotype. (2012) pubmed
- Tramadol. (2006) pubmed
- Tramadol--Biovail Corporation. (2004) pubmed
- Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. (2008) pubmed
- The role of tramadol ER in the treatment of chronic pain. (2009) pubmed
- Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. (2008) pubmed
- Potent Ameliorative Effects of Rosmarinic Acid on Tramadol-Induced Neurotoxicity in the Brain and Hippocampus; by Suppressing Oxidative stress, Apoptosis, ER stress, and Regulating Cognitive Functions. (2025) pubmed
- Tramadol induced hypoxia signaling and paraptosis-like cell death in breast cancer cells via HIF-1α and ATF4 dependent pathways. (2026) pubmed